Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

SCYNEXIS to Present at the 30th Annual ROTH Conference


JERSEY CITY, N.J., March 7, 2018 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, today announced that the Company will present at the 30th Annual ROTH Conference at the Ritz Carlton Laguna Niguel in Dana Point on Tuesday, March 13, 2018 at 7:30 a.m. PT.

A live webcast will be available on the Investors section of the Company's website: www.scynexis.com. A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.

About SCYNEXIS
SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas. The Company's lead product candidate, SCY-078, is a novel IV/oral antifungal agent in Phase 2 clinical and preclinical development for the treatment of several serious and life-threatening invasive fungal infections caused by Candida and Aspergillus species. For more information, visit www.scynexis.com.

CONTACT:

Investor Relations
Susan Kim
Argot Partners
Tel: 212-203-4433
[email protected]

Media Relations
George E. MacDougall
MacDougall Biomedical Communications
Tel: 781-235-3093
[email protected] 

 

SOURCE SCYNEXIS, Inc.


These press releases may also interest you

at 18:45
IANS Research Receives Strategic Investment From the Apax Digital Funds to Accelerate Growth and Market Leadership in Information Security
IANS Research, the leading provider of independent research and advisory services for the information security industry, has announced a new strategic investment from the Apax Digital Fund II (the "Apax Digital Funds"). IANS is a widely recognized...

at 18:45
Monster Energy Snowboard Athletes Release Visually Stunning "Green Hour" Video
Monster Energy Releases Nine-Minute Video Showcasing Professional Snowboarders Ståle Sandbech, Torgeir Bergrem, and Rene Rinnekangas Riding Beneath the Northern Lights in the Backcountry of Norway "We had this vision or this idea to...

at 18:37
University of Maryland's Smith School of Business Launches Center for Artificial Intelligence in Business
The University of Maryland's Robert H. Smith School of Business has launched the Center for Artificial Intelligence in Business to conduct research and outreach in order to realize the potential of AI through intentional design and governance...

at 18:00
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plustm, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:50
Cantaloupe, Inc. to Report Third Quarter Fiscal Year 2024 Results on May 9, 2024
Cantaloupe, Inc. , a leading provider of end-to-end technology solutions for self-service commerce, today announced that management will host a webcast to discuss its financial results for the third quarter of fiscal year 2024 on Thursday, May 9,...

at 17:31
DRI Healthcare Trust Closes Previously Announced Refinancing of Preferred Securities
DRI Healthcare Trust (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 warrants were...

More news about Science and technology...


News published on and distributed by: